Processes for regulating blood glucose in a mammal

Details Processes for regulating blood glucose in a mammal Processes for regulating blood glucose in a mammal

2006-10-03

2010-06-15

Swope, Sheridan (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

07737158

ABSTRACT:
The present invention relates to processes for regulating the blood glucose concentration of a mammal.

REFERENCES:
patent: 2005-213206 (2005-08-01), None
patent: 2005/072767 (2005-08-01), None
patent: 2006/041624 (2006-04-01), None
Revollo et al, Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. Nov. 2007;6(5):363-75.
Araki, T., et al., “Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration,” Science, Aug. 13, 2004, pp. 1010-1013, vol. 305, American Association for the Advancement of Science.
Arner, P., “Editorial: Visfatin—A True or False Trail to Type 2 Diabetes Mellitus,” The Journal of Clinical Endocrinology & Metabolism, Jan. 2006, pp. 28-30, vol. 91, No. 1.
Bailey, S. D., et al., “Common Polymorphisms in the Promoter of the Visfatin Gene (PBEF1) Influence Plasma Insulin Levels in a French-Canadian Population,” Diabetes, Oct. 2006, pp. 2896-2902, vol. 55.
Berndt, J., et al., “Plasma Visfatin Concentrations and Fat Depot-Specific mRNA Expression in Humans,” Diabetes, Oct. 2005, pp. 2911-2916, vol. 54.
Bordone, L., et al., “Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β Cells,” PLoS Biology, Feb. 2006, pp. 0210-0220, vol. 4, No. 2.
Chen, M-P., et al., “Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus,” The Journal of Clinical Endocrinology & Metabolism, Jan. 2006, pp. 295-299, vol. 91, No. 1.
Denu, J. M. “Linking Chromatin Function with Metabolic Networks: Sir2 Family of NAD+ -Dependent Deacetylases,” TRENDS in Biochemical Sciences, Jan. 2003, pp. 41-48, vol. 28, No. 1.
Haider, D. G., et al., “The Release of the Adipocytokine Visfatin is Regulated by Glucose and Insulin,” Diabetologia, May 31, 2006, pp. 1909-1914, vol. 49.
Hasmann, M., et al., “FK866, A Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis,” Cancer Research, Nov. 1, 2003, pp. 7436-7442, vol. 63.
Imai, S-I., et al., “Transcriptional Silencing and Longevity Protein Sir2 is an NAD-Dependent Histone Deacetylase,” Nature, Feb. 17, 2000, pp. 795-800, vol. 403.
Khan, J. A., et al., “Molecular Basis for the Inhibition of Human NMPRTase, A Novel Target for Anticancer Agents,” Nature Structural & Molecular Biology, Jul. 2006, pp. 582-588, vol. 13, No. 7.
Kim, M-K., et al., “Crystal Structure of Visfatin/Pre-B Cell Colony-Enhancing Factor 1/Nicotinamide Phosphoribosyltransferase, Free and in Complex with the Anti-Cancer Agent FK-866,” J. Mol. Biol., 2006, pp. 66-77, vol. 362.
Kitani, T., et al., “Growth Phase-Dependent Changes in the Subcellular Localization of Pre-B-Cell Colony-Enhancing Factor,” FEBS Letters, May 13, 2003, pp. 74-78, vol. 544.
Martin, P. R., et al., “Identification of a Plasmid-Encoded Gene fromHaemophilus ducreyiWhich Confers NAD Independence,” Journal of Bacteriology, Feb. 2001, pp. 1168-1174, vol. 183, No. 4.
Moynihan, K. A., et al., “Increased Dosage of Mammalian Sir2 in Pancreatic β Cells Enhances Glucose-Stimulated Insulin Secretion in Mice,” Cell Metabolism, Aug. 2005, pp. 105-117, vol. 2.
Pagano, C., et al., “Reduced Plasma Visfatin/Pre-B Cell Colony-Enhancing Factor in Obesity is not Related to Insulin Resistance in Humans,” The Journal of Clinical Endocrinology & Metabolism, Aug. 2006, pp. 3165-3170, vol. 91, No. 8.
Picard, F., et al., “Sirt1 Promotes Fat Mobilization in White Adipocytes by Repressing PPAR-γ,” Nature, Jun. 17, 2004, pp. 771-776, 921, vol. 429.
Revollo, J. R., et al., “The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells,” The Journal of Biological Chemistry, Dec. 3, 2004, pp. 50754-50763, vol. 279, No. 49.
Rodgers, J. T., et al., “Nutrient Control of Glucose Homeostatis Through a Complex of PGC-1α and SIRT1,” Nature, Mar. 3, 2005, pp. 113-118, vol. 434.
Rongvaux, A., et al., “Pre-B-Cell Colony-Enhancing Factor, Whose Expression is Up-Regulated in Activated Lymphocytes, is a Nicotinamide Phosphoribosyltransferase, A Cytosolic Enzyme Involved in NAD Biosynthesis,” Eur. J. Immunol., 2002, pp. 3225-3234, vol. 32.
Rongvaux, A., et al., “Reconstructing Eukaryotic NAD Metabolism,” BioEssays, 2003, pp. 683-690, vol. 25, No. 7.
Samal, B., et al., “Cloning and Characterization of the cDNA Encoding a Novel Human Pre-B-Cell Colony-Enhancing Factor,” Molecular and Cellular Biology, Feb. 1994, pp. 1431-1437, vol. 14, No. 2.
Sethi, J. K., et al., “Visfatin: The Missing Link Between Intra-Abdominal Obesity and Diabetes?,” TRENDS in Molecular Medicine, Aug. 2005, pp. 344-347, vol. 11, No. 8.
Stephens, J. M., et al., “An Update on Visfatin/Pre-B Cell Colony-Enhancing Factor, An Ubiquitously Expressed, Illusive Cytokine That is Regulated in Obesity,” Current Opinion in Lipidology, 2006, pp. 128-131, vol. 17.
van der Veer, E., et al., “Pre-B-Cell Colony-Enhancing Factor Regulates NAD+-Dependent Protein Deacetylase Activity and Promotes Vascular Smooth Muscle Cell Maturation,” Circulation Research, Jun. 9, 2005, pp. 25-34, vol. 97.
Wang, T., et al., “Structure of Nampt/PBEF/Visfatin, A Mammalian NAD+ Biosynthetic Enzyme,” Nature Structural & Molecular Biology, Jul. 2006, pp. 661-662, vol. 13, No. 7.

Affiliated with

Also associated with

Rating

Processes for regulating blood glucose in a mammal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Processes for regulating blood glucose in a mammal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for regulating blood glucose in a mammal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4161719